UAB researchers found that, from 2012-2014, Medicare was the primary payer for more than 90 percent of TAVR procedures.
The infiltration of macrophages into the heart is a required step on the path to heart failure in a preclinical model.
UAB research shows that splenic leukocytes resolve inflammation in heart failure.

Arora will be involved in assigning manuscripts focused on genetics, omics and precision medicine as it relates to cardiovascular disease.

Much like other muscles, when the heart works during the normal daytime hours, it needs a period of rest to repair itself.
Research shows protection against the linked heart damage and kidney dysfunction known as cardiorenal syndrome.
Researchers have found the rate of hospitalization for sarcoidosis has increased, and in-hospital mortality associated with sarcoidosis has decreased.
Throughout February, UAB Heart and Vascular Services will raise awareness about heart disease.

Natriuretic peptides are routinely used as “gold-standard” biomarkers for diagnosis of heart disease.

UAB is one of only three hospitals in the United States to receive a three-star ranking in each of the five categories of surgery.

This more comprehensive approach may be needed to find ways to delay the progressive heart failure.
Harden Davis couldn’t walk 30 feet without having shortness of breath; but thanks to UAB doctors, he now breathes easy and has renewed energy.
CHAAMPS exists to develop, implement and evaluate interventions to improve African-American men’s health through research, outreach and training.
UAB Hospital houses a 21-bed cardiac care unit specializing in procedures such as heart transplants and cardiopulmonary rehabilitation.

Started in 1981, the Mr. and Ms. UAB Scholarship Competition is one of UAB’s longest-standing Homecoming traditions.

Low dietary potassium leads to calcified arteries and aortic stiffness, while increased dietary potassium alleviates those undesirable effects in a mouse model, suggesting dietary potassium may protect against heart disease and death from heart disease in humans.
A UAB spinoff has received a stage two grant to test a potential solution for malfunctioning vascular access.
UAB Medicine has a long history of caring for patients with adult congenital heart disease, and the Alabama Adult Congenital Heart Program is the only one in Alabama and one of a handful in the country that provide continuing care for patients as they move into adulthood.
A program that supports historically disadvantaged health professionals chooses two researchers in the UAB Department of Medicine as finalists.

A fatty acid-derived bioactive molecule called lipoxin improved heart function after a heart attack, as the lipoxin prompted early activation of the resolving phase of the immune response.

Page 1 of 5
Back to Top